Related references
Note: Only part of the references are listed.Low-dose total skin electron beam therapy as a debulking agent for cutaneous T-cell lymphoma: an open-label prospective phase II study
M. R. Kamstrup et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Bexarotene Is Active Against Subcutaneous Panniculitis-Like T-Cell Lymphoma in Adult and Pediatric Populations
Neha Mehta et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2012)
Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012
Reinhard Dummer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
Barbara Pro et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
World Health Organization-European Organization for Research and Treatment of Cancer classification of cutaneous lymphoma in Korea: A retrospective study at a single tertiary institution
Ji-Hye Park et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma
Werner Kempf et al.
BLOOD (2011)
Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
Elise A. Olsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase III Placebo-Controlled Trial of Denileukin Diftitox for Patients With Cutaneous T-Cell Lymphoma
H. Miles Prince et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
Sean J. Whittaker et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
How I treat mycosis fungoides and Sezary syndrome
H. Miles Prince et al.
BLOOD (2009)
LOW-DOSE PALLIATIVE RADIOTHERAPY FOR CUTANEOUS B- AND T-CELL LYMPHOMAS
Karen J. Neelis et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas
Nancy J. Senff et al.
BLOOD (2008)
Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases
Rein Willemze et al.
BLOOD (2008)
Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma
R. F. Duarte et al.
BONE MARROW TRANSPLANTATION (2008)
Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma
Nancy J. Senff et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Treatment of primary cutaneous CD30+anaplastic large-cell lymphoma with radiation therapy
James B. Yu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
Elise Olsen et al.
BLOOD (2007)
Phase IIB multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma
Elise A. Olsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)
Youn H. Kim et al.
BLOOD (2007)
Low-dose intermittent alemtuzumab in the treatment of Sezary syndrome: clinical and immunologic findings in 14 patients
Maria Grazia Bernengo et al.
HAEMATOLOGICA (2007)
EORTC consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome
Franz Trautinger et al.
EUROPEAN JOURNAL OF CANCER (2006)
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma - Phase II study of 32 patients
E Marchi et al.
CANCER (2005)
CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature
MW Bekkenk et al.
ANNALS OF ONCOLOGY (2004)
Cutaneous lymphomas other than mycosis fungoides in Singapore: a clinicopathological analysis using recent classification systems
SH Tan et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Joint British Association of Dermatologists and UK Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas
SJ Whittaker et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies
R Russell-Jones
BRITISH JOURNAL OF DERMATOLOGY (2000)
Share Paper
